A single-chain 55,000-mol wt form of urokinase (UK), similar to that previously isolated from urine, was purified from a transformed kidney cell culture medium and characterized; and its fibrinolytic properties were evaluated. The preparation immunoprecipitated with UK antiserum, had a low intrinsic amidolytic activity that was 0.1% of its active derivative, and resisted diisopropyl fluorophosphate treatment and inactivation by plasma inhibitors. The single-chain UK was therefore designated pro-UK. In the presence of plasmin and during clot lysis, activation by conversion to two-chain, 55,000-mol wt UK (TC-UK) was demonstrated. This did not occur during blood clotting nor on incubation with purified thrombin. Clot lysis in plasma consistently occurred in 2-5 h with 50-100 IU per ml of pro-UK, whereas comparable lysis was inconsistently achieved by 500-1,000 IU of UK. Pro-UK, in sharp contrast to UK, caused no fibrinogen degradation at fibrinolytic concentrations. In the absence of a clot, pro-UK in plasma was stable for more than 2 d. When a clot was added after incubation (37 degrees C) for 50 h, activation to full lytic activity took place. The findings in vivo were comparable but the rapid clearance of pro-UK required that it be given by a constant infusion despite its plasma stability. In rabbits, a UK-resistant species, pro-UK was significantly (P less than 0.001) more efficacious than TC-UK but neither induced significant fibrinogen degradation. In dogs, a more sensitive species, the high specificity of thrombolysis by pro-UK contrasted with the defibrinogenation and uncontrollable bleeding that accompanied thrombolysis by UK. It was concluded that clot lysis by pro-UK is more effective and specific than UK. The advantage of pro-UK is in the limitation of its activation to the site of a clot. This can be explained by an activation mechanism that is dependent, under physiological conditions, on fibrin-stabilized plasmin.
V Gurewich, R Pannell, S Louie, P Kelley, R L Suddith, R Greenlee
Year: | 2023 | 2021 | 2020 | 2019 | 2017 | 2016 | 2013 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 | 1984 | 1983 | 1969 | 1962 | 1953 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 3 | 2 | 3 | 1 | 3 | 1 | 2 | 2 | 1 | 4 | 4 | 7 | 3 | 5 | 4 | 8 | 11 | 10 | 9 | 11 | 14 | 17 | 21 | 27 | 22 | 21 | 11 | 3 | 1 | 1 | 1 | 1 | 243 |
Title and authors | Publication | Year |
---|---|---|
Fibrin and Fibrinolytic Enzyme Cascade in Thrombosis: Unravelling the Role.
Singh R, Gautam P, Sharma C, Osmolovskiy A |
2023 | |
The ANXA2/S100A10 Complex—Regulation of the Oncogenic Plasminogen Receptor
AG Bharadwaj, E Kempster, DM Waisman |
Biomolecules | 2021 |
Peripheral Nerve Tissue Engineering and Regeneration
J Phillips, D Hercher, T Hausner |
2020 | |
Emerging paradigms in nanotechnology for imaging and treatment of cerebral ischemia
S Kaviarasi, E Yuba, A Harada, UM Krishnan |
Journal of Controlled Release | 2019 |
Thrombolysis with rhPro-UK 3 to 6 hours after embolic stroke in rat
CH Hao, WX Ding, Q Sun, XX Li, WT Wang, ZY Zhao, LD Tang |
Neurological Research | 2019 |
Fibrinolysis: a Misunderstood Natural Defense Whose Therapeutic Potential Is Unknown
V Gurewich |
Cardiovascular Drugs and Therapy | 2019 |
Effect of recombinant human prourokinase on thrombolysis in a rabbit model of thromboembolic stroke
C Hao, W Ding, X Xu, Q Sun, X Li, W Wang, Z Zhao, L Tang |
Biomedical Reports | 2017 |
Trauma Induced Coagulopathy
E Gonzalez, HB Moore, EE Moore |
2016 | |
Thrombus-Targeted Nanocarrier Attenuates Bleeding Complications Associated with Conventional Thrombolytic Therapy
S Absar, K Nahar, YM Kwon, F Ahsan |
Pharmaceutical Research | 2013 |
Mutant Prourokinase with Adjunctive C1-Inhibitor Is an Effective and Safer Alternative to tPA in Rat Stroke
S Tomasi, P Sarmientos, G Giorda, V Gurewich, A Vercelli, C Kleinschnitz |
PloS one | 2011 |
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee |
Annual Reports in Medicinal Chemistry Volume 46 | 2011 |
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken |
Advances in Cancer Research Volume 110 | 2011 |
Medium optimization and immobilization of purified fibrinolytic URAK from Bacillus cereus NK1 on PHB nanoparticles
V Deepak, S Ilangovan, MV Sampathkumar, MJ Victoria, SP Pasha, SB Pandian, S Gurunathan |
Enzyme and microbial technology | 2010 |
Rutherford's Vascular Surgery
HA Liebman, IC Weitz |
Rutherford's Vascular Surgery | 2010 |
New insights into the molecular mechanisms of the fibrinolytic system
DC Rijken, HR Lijnen |
Journal of Thrombosis and Haemostasis | 2009 |
The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator
JY Kim, JK Kim, JS Park, Y Byun, CK Kim |
Biomaterials | 2009 |
Effect of Recombinant Single-Chain Urokinase-Type Plasminogen Activator on Experimental Pulmonary Embolism
Y Wang, C Wang, Y Yang, B Pang |
Clinical and Applied Thrombosis/Hemostasis | 2009 |
Fundamental and Clinical Cardiology Series
PD Stein |
Cardiovascular Disease in the Elderly | 2008 |
Thrombin-thrombomodulin inhibits prourokinase-mediated pleural mesothelial cell-dependent fibrinolysis
AV Iakhiaev, A Nalian, K Koenig, S Idell |
Thrombosis Research | 2007 |
Cardiovascular Medicine
JT Willerson, HJ Wellens, JN Cohn, DR Holmes |
2007 | |
Synthesis, Characterization, and in Vitro Activity of Dendrimer−Streptokinase Conjugates
X Wang, R Inapagolla, S Kannan, M Lieh-Lai, RM Kannan |
Bioconjugate Chemistry | 2007 |
The Vascular Endothelium II
S Moncada, A Higgs |
2006 | |
Molecular mechanisms of fibrinolysis
G Cesarman-Maus, KA Hajjar |
British Journal of Haematology | 2005 |
Fibrin(ogen)olytic character of FIIaisolated from Agkistrodon acutus venom
Y WANG, X LIANG, J CHEN, Q CHEN, P QIU, X LIN, G YAN |
Acta Pharmacologica Sinica | 2005 |
Construction and characterization of a recombinant plasminogen activator composed of an anti-fibrin single-chain antibody and low-molecular-weight urokinase
CE Hagemeyer, I Tomic, U Weirich, J Graeber, T Nordt, MS Runge, C Bode, K Peter |
Journal of Thrombosis and Haemostasis | 2004 |
Complementary and Alternative Approaches to Biomedicine
EL Cooper, N Yamaguchi |
2004 | |
Catheter-directed Thrombolytic Therapy for Limb Ischemia: Current Status and Controversies
MK Razavi, DS Lee, LV Hofmann |
Journal of Vascular and Interventional Radiology | 2003 |
Prourokinase mutant that induces highly effective clot lysis without interfering with hemostasis
JN Liu, JX Liu, BL Bf, Z Sun, JL Zuo, PZ Px, J Zhang, YC Yh, V Gurewich |
Circulation research | 2002 |
Amino-terminal fragment of urokinase-type plasminogen activator inhibits its plasminogen activation
Z Sun, PX Zhang, P Wang, V Gurewich, HY Shen, JN Liu |
Thrombosis Research | 2002 |
Plasminogen activator inhibitor-1 and the kidney
AA Eddy |
American journal of physiology. Renal physiology | 2002 |
Notfallbehandlung des akuten Koronarsyndroms
HR Arntz, DC Gulba, U Tebbe |
2002 | |
High-level expression and characterization of single chain urokinase-type plasminogen activator (scu-PA) produced in recombinant Chinese hamster ovary (CHO) cells
JS Kim, MK Min, EC Jo |
Biotechnology and Bioprocess Engineering | 2001 |
Elements of the Fibrinolytic System
H Lijnen |
Annals of the New York Academy of Sciences | 2001 |
Fibrinolytics and Antifibrinolytics
F Bachmann |
2001 | |
Recombinant Protein Drugs
P Buckel |
2001 | |
Kirk-Othmer Encyclopedia of Chemical Technology
GR Lenz, HG Schoepke, TC SPAULDING |
Kirk-Othmer Encyclopedia of Chemical Technology | 2000 |
Fibrinolysis: an unfinished agenda
V Gurewich |
Blood Coagulation and Fibrinolysis | 2000 |
Catalytic and fibrinolytic properties of recombinant urokinase plasminogen activator from E. coli, mammalian, and yeast cells
P Wang, J Zhang, Z Sun, Y Chen, V Gurewich, J Liu |
Thrombosis Research | 2000 |
Recent developments in thrombolytic therapy
D Collen, HR Lijnen |
Fibrinolysis and Proteolysis | 2000 |
Tumor cell-mediated proteolysis: regulatory mechanisms and functional consequences
S Ghosh, SM Ellerbroek, Y Wu, MS Stack |
Fibrinolysis and Proteolysis | 2000 |
Coronary Circulation and Myocardial Ischemia
MR Pinsky, A Artigas, JF Dhainaut |
2000 | |
Molecular basis of thrombolytic therapy
H Lijnen, D Collen |
Journal of Nuclear Cardiology | 2000 |
Pharmacology and clinical trial results of saruplase (scuPA) in acute myocardial infarction
M Moser, C Bode |
Expert Opinion on Investigational Drugs | 1999 |
Management of Acute Coronary Syndromes
CP Cannon |
1999 | |
Pharmacokinetics and hemostatic effects of saruplase in patients with acute myocardial infarction: comparison of infusion, single-bolus, and split-bolus administration
H R Michels, J J Hoffman, F W Bär |
Journal of Thrombosis and Thrombolysis | 1999 |
Plasminogen activator in acute myeloid leukaemic marrows: u-PA in contrast to t-PA in normal marrow
N Mcwilliam, L Robbie, N Booth, B Bennett |
British Journal of Haematology | 1998 |
CLINICAL APPLICATIONS OF THROMBOLYTIC THERAPY FOR ARTERIAL AND GRAFT OCCLUSION
MD Malone, L Barber, AJ Comerota |
Surgical Clinics of North America | 1998 |
Thrombolytic agents — an updated overview
DC Gulba, C Bode, MS Runge, K Huber |
Fibrinolysis and Proteolysis | 1998 |
Plasma clearance of urokinase-type plasminogen activator
ME der Kaaden, DC Rijken, TJ Berkel, J Kuiper |
Fibrinolysis and Proteolysis | 1998 |
Herz-Kreislauf-Erkrankungen
D Ganten, K Ruckpaul |
1998 | |
Thrombolytic therapy of acute myocardial infarction with saruplase, a single-chain urokinase-type plasminogen activator (scu-PA) from recombinant bacteria
U Tebbe, WA Günzler, GR Hopkins, T Grymbowski, H Barth |
Fibrinolysis and Proteolysis | 1997 |
Decrease in urokinase-type plasminogen activator (u-PA) levels in patients with non-insulin dependent diabetes mellitus
K Krekora, E Vitacolonna, AD Castelnuovo, A D'Orazio, DD Lucia, G Dooijewaard, F Capani, MB Donati, L Iacoviello |
Fibrinolysis and Proteolysis | 1997 |
Textbook of Coronary Thrombosis and Thrombolysis
RC Becker |
1997 | |
Thrombin Stimulation of Platelets Induces Plasminogen Activation Mediated by Endogenous Urokinase-Type Plasminogen Activator
C Lenich, JN Liu, V Gurewich |
Blood | 1997 |
Inherited defects of the protein C anticoagulant system in childhood thrombo-embolism
U Nowak-Göttl, K Auberger, U Göbel, W Kreuz, R Schneppenheim, H Vielhaber, W Zenz, B Zieger |
European Journal of Pediatrics | 1996 |
REGULATION AND ROLE OF UROKINASE PLASMINOGEN ACTIVATOR IN VASCULAR REMODELLING
V Tkachuk, V Stepanova, PJ Little, A Bobik |
Clinical and Experimental Pharmacology and Physiology | 1996 |
Transluminal Angioplasty, Thrombolysis, and Stenting for Extracranial and Intracranial Cerebral Vascular Disease
RT Higashida, FY Tsai, VV Halbach, CF Dowd, GB Hieshima |
Journal of Interventional Cardiology | 1996 |
Thrombolysis with prourokinase versus urokinase: An in vitro comparison
D Fox, K Ouriel, RM Green, J Stoughton, P Riggs, C Cimino |
Journal of Vascular Surgery | 1996 |
FIBRINOGEN AND FIBRIN-PROTEINS WITH COMPLEX ROLES IN HEMOSTASIS AND THROMBOSIS
B Blombäck |
Thrombosis Research | 1996 |
Preparation and Characterization of a Disulfide-Linked Bioconjugate of Annexin V with the B-Chain of Urokinase: An Improved Fibrinolytic Agent Targeted to Phospholipid-Containing Thrombi
K Tanaka, K Einaga, H Tsuchiyama, JF Tait, K Fujikawa |
Biochemistry | 1996 |
A Site-Directed Mutagenesis of Pro-urokinase Which Substantially Reduces Its Intrinsic Activity
JN Liu, W Tang, ZY Sun, W Kung, R Pannell, P Sarmientos, V Gurewich |
Biochemistry | 1996 |
Comparison of the pharmacokinetics and effects on the hemostatic system of saruplase and urokinase in patients with acute myocardial infarction
J Poeppelmeier, H Beier, J Carlsson, WA Guenzler, R Meierhenrich, GR Hopkins, U Tebbe |
Journal of Thrombosis and Thrombolysis | 1996 |
Effects of changing liver blood flow by exercise and food on kinetics and dynamics of saruplase*
JM van Griensven, KJ Burggraaf, J Gerloff, WA Günzler, H Beier, R Kroon, LG Huisman, RC Schoemaker, K Kluft, AF Cohen |
Clinical Pharmacology & Therapeutics | 1995 |
Centrifugal and roller pumps — are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass?
BE Steinbrueckner, U Steigerwald, F Keller, K Neukam, O Elert, J Babin-Ebell |
Heart and Vessels | 1995 |
Sequential combination thrombolytic therapy for acute myocardial infarction: results of the pro-urokinase and t-PA enhancement of thrombolysis (PATENT) trial
SW Zarich, GJ Kowalchuk, WD Weaver, J Loscalzo, M Sassower, K Manzo, C Byrnes, JE Muller, V Gurewich |
Journal of the American College of Cardiology | 1995 |
Fibrinolytic Mechanism, Biochemistry, and Preclinical Pharmacology of Recombinant Prourokinase
RB Credo, SE Burke |
Journal of Vascular and Interventional Radiology | 1995 |
A combination of recombinant single-chain urokinase-type plasminogen activator and streptokinase has a synergistic non-fibrin specific action on in vitro clot lysis
GV Bashkov, JV Jitkova |
Fibrinolysis | 1995 |
Thrombolytic properties of pro-urokinase mutants with mutation in the epidermal growth factor-like domain
K Yano, H Morimoto, M Morita, T Tanabe |
Fibrinolysis | 1995 |
1 Mechanisms of physiological fibrinolysis
HR Lijnen, D Collen |
Baillière's Clinical Haematology | 1995 |
Fibrinolytic agents
F Bachmann |
Fibrinolysis | 1995 |
Pharmacokinetic and biochemical properties of human pro-urokinase variants carrying amino acids substitutions in the epidermal growth factor-like domain
M Morita, M Hirose, Y Amatsuji, S Hase, H Ishikawa, H Tamashima, E Asakura, M Ohkubo, T Tanabe |
Fibrinolysis | 1995 |
Interaction of Single-chain Urokinase and Plasminogen Activator Inhibitor Type 1
N Manchanda, BS Schwartz |
The Journal of biological chemistry | 1995 |
A double-blind multicenter comparison of the efficacy and safety ofsaruplase andurokinase in thetreatment ofacutemyocardialinfarction: Report of the SUTAMI study group
R Michels, H Hoffmann, J Windeler, H Barth, G Hopkins |
Journal of Thrombosis and Thrombolysis | 1995 |
Mechanisms of plasminogen activation
HR Lijnen, F Bachmann, D Collen, V Ellis, H Pannekoek, DC Rijken, S Thorsen |
Journal of Internal Medicine | 1994 |
Activation of thrombin-inactivated single-chain urokinase-type plasminogen activator by dipeptidyl peptidase I (cathepsin C)
U NAULAND, DC RIJKEN |
European Journal of Biochemistry | 1994 |
Characterization of the Binding of Urokinase-type Plasminogen Activator (u-PA) to Plasminogen, to Plasminogen-activator Inhibitor-1 and to the u-PA Receptor
HR Lijnen, F Cock, D Collen |
European Journal of Biochemistry | 1994 |
Thrombolytic Agents
V Gurewich |
New England Journal of Medicine | 1994 |
Overview on fibrinolysis: Plasminogen activation pathways on fibrin and cell surfaces
E Anglés-Cano |
Chemistry and Physics of Lipids | 1994 |
Advances in Pharmacology
B Drenger, Y Ginosar, Y Gozal |
Advances in Pharmacology | 1994 |
Practical Peripheral Arterial Thrombolysis
JJ Earnshaw |
Practical Peripheral Arterial Thrombolysis | 1994 |
Thrombolytic properties of an immunoconjugate between single-chain urokinase-type plasminogen activator (scu-PA) and F(ab′)2 of bispecific monoclonal antibody against fibrin and against u-PA in hamsters
T Kurokawa, A Watanabe, A Kakinuma, S Iwasa |
Fibrinolysis | 1994 |
Thrombolytic Therapy in Acute Stroke
RT Higashida, VV Halbach, SL Barnwell, CF Dowd, GB Hieshima |
Journal of Endovascular Therapy | 1994 |
Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase)
MS Stack, DA Johnson |
The Journal of biological chemistry | 1994 |
RP-HPLC peptide mapping methods for the analysis of recombinant human pro-urokinase
I Facchetti, A Valla, A Vigevani |
Journal of Pharmaceutical and Biomedical Analysis | 1993 |
Pro-urokinase and prekallikrein are both associated with platelets
V Gurewich, M Johnstone, JP Loza, R Pannell |
FEBS Letters | 1993 |
The role of urokinase generation during clot lysis by pro-urokinase in a plasma milieu
C Giorgetti, A Molinari, L Bonomini, J Lansen, V Gurewich |
Fibrinolysis | 1993 |
A study of the activation of fibrin-bound plasminogen by tissue-type plasminogen activator, single chain urokinase and sequential combinations of the activators
V Fleury, V Gurewich, E Anglés-Cano |
Fibrinolysis | 1993 |
New Insights into the Pathogenesis of Coagulation Dysfunction in Acute Promyelocytic Leukemia
MS Tallman, D Hakimian, HC Kwaan, FR Rickles |
Leukemia & Lymphoma | 1993 |
Thrombolytic Therapy: A Comprehensive Review of its Use in Clinical Medicine—Part I
WR Bell, MB Streiff |
Journal of Intensive Care Medicine | 1993 |
NMR studies of the dynamics of the multidomain protein urokinase-type plasminogen activator
UK Nowak, X Li, AJ Teuten, RA Smith, CM Dobson |
Biochemistry | 1993 |
Coronary rethrombosis after successful thrombolysis
V Gurewich |
Circulation | 1993 |
Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis
V Fleury, HR Lijnen, E Anglés-Cano |
The Journal of biological chemistry | 1993 |
Biochemical properties of recombinant single-chain urokinase-type plasminogen activator mutants with deletion of Asn2 through Phe157 and/or substitution of Cys279 with Ala
HR LIJNEN, XK LI, L NELLES, MH HU, D COLLEN |
European Journal of Biochemistry | 1992 |
Multicenter dose-finding trial for thrombolysis with urokinase preactivated pro-urokinase (TCL 598) in acute myocardial infarction
DC Gulba, C Bode, S Sen, J Topp, K Fischer, H Wolf, H Hecker |
Catheterization and Cardiovascular Diagnosis | 1992 |
Biochemical properties of recombinant mutants of nonglycosylated single chain urokinase-type plasminogen activator
XK Li, HR Lijnen, L Nelles, MH Hu, D Collen |
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology | 1992 |
Pharmacokinetics and biochemical properties of human pro-urokinase variants carrying the deletion in epidermal growth factor-like domain
M Morita, M Hirose, Y Amatsuji, T Kawai, M Ohkubo, H Emoto, T Tanabe, H Kawabe, K Yokoyama |
Fibrinolysis | 1992 |
A comparison of the rates of clot lysis in a plasma milieu induced by tissue plasminogen activator (t-PA) and rec-pro-urokinase: Evidence that t-PA has a more restricted mode of action
R Pannell, V Gurewich |
Fibrinolysis | 1992 |
Differential detection of single chain urokinase-type plasminogen activator and two chain urokinase-type plasminogen activator in human and monkey plasma
A Molinari, C Giorgetti, L Bonomini, M Gerna, J Lansen, V Gurewich |
Fibrinolysis | 1992 |
Thrombolytic Therapy in Arterial Disease. I: Available Agents
WS Hillis, JD Gemmill, PD Macintyre, B Bhargava |
1992 | |
A practical method for uniform isotopic labeling of recombinant proteins in mammalian cells
AP Hansen, AM Petros, AP Mazar, TM Pederson, A Rueter, SW Fesik |
Biochemistry | 1992 |
Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK
J Liu, V Gurewich |
Biochemistry | 1992 |
A transitional state of pro-urokinase that has a higher catalytic efficiency against glu-plasminogen than urokinase
JN Liu, R Pannell, V Gurewich |
The Journal of biological chemistry | 1992 |
Structural requirements for the growth factor activity of the amino-terminal domain of urokinase
SA Rabbani, AP Mazar, SM Bernier, M Haq, I Bolivar, J Henkin, D Goltzman |
The Journal of biological chemistry | 1992 |
A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin
JN Liu, V Gurewich |
Journal of Clinical Investigation | 1991 |
Topically applied antithrombotic agents offer a new therapeutic approach to the prevention of microvascular thrombosis
BC Cooley, JS Gould |
Microsurgery | 1991 |
Importance of viability and attachment to an ascites tumor in the release of plasminogen activator
Q Dong, M Zhou, V Subbarao, C Ts'ao |
The American Journal of Pathology | 1991 |
Substrate specificity of tissue-type and urokinase-type plasminogen activators
DC Rijken, E Groeneveld |
Biochemical and Biophysical Research Communications | 1991 |
Efficient renaturation and fibrinolytic properties of prourokinase and a deletion mutant expressed in Escherichia coli as inclusion bodies
G ORSINI, A BRANDAZZA, P SARMIENTOS, A MOLINARI, J LANSEN, G CAUET |
European Journal of Biochemistry | 1991 |
Monoclonal Antibodies Monospecific to Single-Chain Urokinase-Type Plasminogen Activator (scu-PA)
JG Scheuerlein, I Kalies, WP Gluth, JR Kalden |
Hybridoma | 1991 |
The effect of the carboxy-terminal lysine of urokinase on the catalysis of plasminogen activation
C Lenich, R Pannell, V Gurewich |
Thrombosis Research | 1991 |
Taprostene, a stable prostacyclin analogue, enhances the thrombolytic efficacy of saruplase (recombinant single-chain urokinase-type plasminogen activator) in rabbits with pulmonary embolized thrombi
J Schneider |
Prostaglandins | 1991 |
Biotechnology of Blood
BJ Kudryk, A Bini, SF Rosebrough, TF Schaible |
Biotechnology of Blood | 1991 |
Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities
SS Husain |
Biochemistry | 1991 |
Thrombosis, fibrinolysis, and thrombolytic therapy: A perspective
S Sherry, VJ Marder |
Progress in Cardiovascular Diseases | 1991 |
Transient increase of plasma lipoprotein(a) in patients with unstable angina pectoris. Does lipoprotein(a) alter fibrinolysis?
S Oshima, K Uchida, T Yasu, K Uno, H Nonogi, K Haze |
Arteriosclerosis Thrombosis and Vascular Biology | 1991 |
Single chain urokinase. Augmentation of enzymatic activity upon binding to monocytes
N Manchanda, BS Schwartz |
The Journal of biological chemistry | 1991 |
Cardiovascular Therapies in the 1990s: An Overview
RC Becker, JM Gore |
Drugs | 1991 |
Spin Filter Perfusion System for High Density Cell Culture: Production of Recombinant Urinary Type Plasminogen Activator in CHO Cells
GC Avgerinos, D Drapeau, JS Socolow, J Mao, K Hsiao, RJ Broeze |
Bio/Technology | 1990 |
Coronary reperfusion studies with pro-urokinase in acute myocardial infarction: Evidence for synergism of low dose urokinase
W Kasper, SH Hohnloser, H Engler, T Meinertz, J Wilkens, E Roth, K Lang, P Limbourg, H Just |
Journal of the American College of Cardiology | 1990 |
Treatment of acute vascular occlusions with intra-arterial urokinase
DE Eisenbud, BJ Brener, R Shoenfeld, D Creighton, RJ Goldenkranz, DK Brief, J Alpert, J Huston, A Novick, UR Krishnan, V Parsonnet, J Nozick, P Cordero |
The American Journal of Surgery | 1990 |
Fibrinolytic properties of single chain urokinase-type plasminogen activator (Pro-urokinase)
GA Munk, DC Rijken |
Fibrinolysis | 1990 |
6 Mechanism of action of the thrombolytic agents
JI Weitz |
Baillière's Clinical Haematology | 1990 |
Construction, expression and biochemical characterisation of a novel triskringle plasminogen activator gene
NK Kalyan, J Wilhelm, SG Lee, SK Dheer, S Cheng, R Hjorth, WA Pierzchala, F Wiener, PP Hung |
Fibrinolysis | 1990 |
Tumour necrosis factor α stimulates the production of pro-urokinase from the A549 lung carcinoma cell line
AM Dosne, F Lutcher, R Beaupain, M Samama |
Fibrinolysis | 1990 |
Thrombolytic and pharmacokinetic properties of a conjugate of recombinant single-chain urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin in a baboon venous thrombosis model
D Collen, M Dewerchin, HJ Rapold, HR Lijnen, JM Stassen |
Circulation | 1990 |
Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator
C Bode, MS Runge, S Schönermark, T Eberle, JB Newell, W Kübler, E Haber |
Circulation | 1990 |
Pathophysiology and Rational Pharmacotherapy of Myocardial Ischemia
G Heusch |
1990 | |
Kinetics of producing pro-urokinase in perfusion cultivations
JK Kang, SK Ghoi, HY Lee |
Biotechnology Letters | 1990 |
Use of plasminogen activators in venous thrombosis
J Hirsh, AG Turpie |
World Journal of Surgery | 1990 |
Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis
CY Liu, S Chien |
1990 | |
Pathophysiologie und rationale Pharmakotherapie der Myokardischämie
G Heusch |
1990 | |
Characterization of a nonglycosylated single chain urinary plasminogen activator secreted from yeast
LM Melnick, BG Turner, P Puma, B Price-Tillotson, KA Salvato, DR Dumais, DT Moir, RJ Broeze, GC Avgerinos |
The Journal of biological chemistry | 1990 |
Thrombospondin forms complexes with single-chain and two-chain forms of urokinase
RL Silverstein, RL Nachman, R Pannell, V Gurewich, PC Harpel |
The Journal of biological chemistry | 1990 |
Inactivation of human tumor cell pro-urokinase by granulocyte elastase.
Kanayama N, Terao T |
Japanese journal of cancer research : Gann | 1990 |
Pharmacologic Control of Wound Healing in Glaucoma Filtration Surgery
MM Tahery, DA Lee |
Journal of Ocular Pharmacology and Therapeutics | 1989 |
Biochemical properties of conjugates of urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin
M DEWERCHIN, HR LIJNEN, B HOEF, F COCK, D COLLEN |
European Journal of Biochemistry | 1989 |
The sequential, complementary and synergistic activation of fibrin-bound plasminogen by tissue plasminogen activator and pro-urokinase
V Gurewich |
Fibrinolysis | 1989 |
Activation of pro-urokinase by plasmin: Non-michaelian kinetics indicates a mechanism of negative cooperativity
MF Scully, V Ellis, Y Watahiki, VV Kakkar |
Archives of Biochemistry and Biophysics | 1989 |
Low dose urokinase preactivated natural prourokinase for thrombolysis in acute myocardial infarction
DC Gulba, K Fischer, M Barthels, U Polensky, GH Reil, WG Daniel, D Welzel, PR Lichtlen |
The American Journal of Cardiology | 1989 |
Potentiative effect of heparin in thrombolytic therapy of evolving myocardial infarction with natural pro-urokinase
DC Gulba, K Fischer, M Barthels, S Jost, W Möller, R Frombach, GH Reil, WG Daniel, PR Lichtlen |
Fibrinolysis | 1989 |
Production and characterisation of human recombinant single chain urokinase-type plasminogen activator from mouse cells
ML Nolli, E Sarubbi, A Corti, F Robbiati, A Soflientini, F Blasi, F Parenti, G Cassani |
Fibrinolysis | 1989 |
Thrombolytic properties of tissue plasminogen activator (t-PA) and single chain urokinase plasminogen activator (scu-PA) in vitro: Absence of synergy as demonstrated by two quantitative analytical methods
G Nguyen, J Fretault, M Samama, J Coursaget |
Fibrinolysis | 1989 |
Immunological properties of fibrin high affinity urokinase inhibitor complex in urine and plasma
S Hayashi, K Yamada |
Fibrinolysis | 1989 |
Influence of heparin and various glycosaminoglycans on activation of single chain urokinase-type plasminogen activator (scu-PA) by plasmin
Y Watahiki, MF Scully, V Ellis, VV Kakkar |
Fibrinolysis | 1989 |
Charge heterogeneity of recombinant pro-urokinase and urinary urokinase, as revealed by isoelectric focusing in immobilized pH gradients
PG Righetti, B Barzaghi, E Sarubbi, A Soffientini, G Cassani |
Journal of Chromatography A | 1989 |
Thrombolytic Therapy for Acute Myocardial Infarction
ER Bates, EJ Topol |
Chest | 1989 |
Circadian variation of plasma fibrinopeptide A level in patients with variant angina
H Ogawa, H Yasue, S Oshima, K Okumura, K Matsuyama, K Obata |
Circulation | 1989 |
Clot-selective coronary thrombolysis with pro-urokinase
J Loscalzo, TP Wharton, JM Kirshenbaum, HJ Levine, JT Flaherty, EJ Topol, K Ramaswamy, BD Kosowsky, DN Salem, P Ganz |
Circulation | 1989 |
Limitation of Infarct Size
H Schmutzler, W Rutsch, FC Dougherty |
1989 | |
Cancer Metastasis
V Schirrmacher, R Schwartz-Albiez |
1989 | |
Electrocardiography and Cardiac Drug Therapy
V Hombach, HH Hilger, HL Kennedy |
1989 | |
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988
J Morganroth, EN Moore |
1989 | |
Newer agents for coronary thrombolysis. Perspectives from clinical studies
GD Minno, M Margaglione, AM Cerbone, R Papa, A Mattei |
Pharmacological research : the official journal of the Italian Pharmacological Society | 1989 |
Thrombolysis in the Management of Acute Myocardial Infarction and Unstable Angina Pectoris:
J Loscalzo |
Drugs | 1989 |
Clinical disorders of fibrinolysis: A critical review
RB Francis |
Blut Zeitschrift für die Gesamte Blutforschung | 1989 |
Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained
R Pannell, J Black, V Gurewich |
Journal of Clinical Investigation | 1988 |
Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158)
V Gurewich, R Pannell, RJ Broeze, J Mao |
Journal of Clinical Investigation | 1988 |
Unresolved clinical pharmacologic questions in thrombolytic therapy for acute myocardial infarction
S Sherry |
Journal of the American College of Cardiology | 1988 |
COMPARISON OF THROMBOLYTIC, FIBRINOLYTIC, AND FIBRINOGENOLYTIC PROPERTIES OF TISSUE PLASMINOGEN ACTIVATOR, STREPTOKINASE, SINGLE-CHAIN UROKINASE, HIGH MOLECULAR WEIGHT AND LOW MOLECULAR WEIGHT UROKINASE IN HUMAN PLASMAIN VITRO
M Samama, G Nguyen, P Desnoyers, D Lourenco, J Fretault, M Horellou, J Conard, E Szwarcer, E Verdy, A Vahanian |
Fundamental & Clinical Pharmacology | 1988 |
A sequence-dependent monoclonal antibody specific for single-chain urokinase
JR Charpie, E Haber, GR Matsueda |
Biochemical and Biophysical Research Communications | 1988 |
Keratinocyte Urokinase-Type Plasminogen Activator is Secreted as a Single Chain Precursor
K Hashimoto, JH Prystowsky, J Baird, GS Lazarus, PJ Jensen |
Journal of Investigative Dermatology | 1988 |
Construction and expression of a hybrid plasminogen activator gene with sequences from non-protease region of tissue-type plasminogen activator (t-PA) and protease region of urokinase (u-PA)
NK Kalyan, SG Lee, SM Cheng, R Hartzell, C Urbano, PP Hung |
Gene | 1988 |
Isolation of a human cDNA of urokinase and its expression in COS-1 cells
SM Cheng, SG Lee, NK Kalyan, WT Hum, M Blume, R Vogel, PP Hung |
Gene | 1988 |
Fibrin-specific thrombolytic therapy
D Collen |
Thrombosis Research | 1988 |
Recombinant single-chain urokinase-type plasminogen activator (rscu-pa) induces thrombolysis and systemic fibrinolysis in a canine model of coronary artery thrombosis
W Söhnge, JK Mickelson, PJ Simpson, BR Lucchesi |
Thrombosis Research | 1988 |
Bolus dose response characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog model of arterial thrombosis
SF Badylak, S Voytik, RE Klabunde, J Henkin, M Leski |
Thrombosis Research | 1988 |
A rapid, simple method for monitoring fibrinolysis
SK Vernon |
Thrombosis Research | 1988 |
Production of an active urokinase by leukemia cells: A novel distinction from cell lines of solid tumors
R Stephens, R Alitalo, H Tapiovaara, A Vaheri |
Leukemia Research | 1988 |
Mechanisms of thrombus formation and lysis
DC Stump, KG Mann |
Annals of Emergency Medicine | 1988 |
Acute pulmonary embolism treated with thrombolytic agents: Current status of tPA and future implications for emergency medicine
CM Kessler, E Druy, SZ Goldhaber |
Annals of Emergency Medicine | 1988 |
Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction
C Bode, S Schoenermark, G Schuler, R Zimmermann, F Schwarz, W Kuebler |
The American Journal of Cardiology | 1988 |
The activation of human [Glu1]plasminogen by human single-chain urokinase
T Urano, VS de Serrano, PJ Gaffney, FJ Castellino |
Archives of Biochemistry and Biophysics | 1988 |
Effect of fibrinogen-clotting enzymes on secretion of plasminogen activators from cultured human endothelial cells
T Soszka, NE Kirschbaum, GJ Stewart, AZ Budzynski |
Fibrinolysis | 1988 |
Spontaneous clot lysis in whole human plasma by endogenous tissue type and urokinase type plasminogen activators: Demonstration of a promoting effect by t-PA and by platelets on urokinase
V Gurewich, F Emmons, R Pannell |
Fibrinolysis | 1988 |
Reperfusion therapy of acute myocardial infarction
WW O'Neill, EJ Topol, B Pitt |
Progress in Cardiovascular Diseases | 1988 |
On future directions for cardiology. The Paul D. White lecture
E Braunwald |
Circulation | 1988 |
Randomized, double-blinded multicenter study. Comparison of intracoronary single-chain urokinase-type plasminogen activator, pro-urokinase (GE-0943), and intracoronary urokinase in patients with acute myocardial infarction
H Kambara, C Kawai, N Kajiwara, H Niitani, S Sasayama, K Kanmatsuse, K Kodama, H Sato, M Nobuyoshi, M Nakashima |
Circulation | 1988 |
New model of cerebral thrombosis in dogs
M Hirschberg, B Hofferberth |
Stroke; a journal of cerebral circulation | 1988 |
Endothelial Cell Biology in Health and Disease
N Simionescu, M Simionescu |
1988 | |
Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells
FM Booyse, PH Lin, M Traylor, R Bruce |
The Journal of biological chemistry | 1988 |
Structure-function analysis with tissue-type plasminogen activator. Effect of deletion of NH2-terminal domains on its biochemical and biological properties
NK Kalyan, SG Lee, J Wilhelm, KP Fu, WT Hum, R Rappaport, RW Hartzell, C Urbano, PP Hung |
The Journal of biological chemistry | 1988 |
One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity
LC Petersen, LR Lund, LS Nielsen, K Danø, L Skriver |
The Journal of biological chemistry | 1988 |
The search for the ideal thrombolytic agent
M Verstraete |
Journal of the American College of Cardiology | 1987 |
Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy
D Collen |
Journal of Cellular Biochemistry | 1987 |
Effect of the cyanogen-bromide-2 fragment of fibrinogen on plasminogen activation by single-chain urokinase-type plasminogen activator
JC KIRCHHEIMER, I RESCH, G CHRIST, J WOJTA, BR BINDER |
European Journal of Biochemistry | 1987 |
A Modified Human Tissue Plasminogen Activator with Extended Half–Life In Vivo
D Lau, G Kuzma, CM Wei, DJ Livingston, N Hsiung |
Bio/Technology | 1987 |
Human monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitor
AC Webb, KL Collins, SE Snyder, SJ Alexander, LJ Rosenwasser, RL Eddy, TB Shows, PE Auron |
Journal of Experimental Medicine | 1987 |
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
F Blasi, JD Vassalli, K Danø |
The Journal of Cell Biology | 1987 |
Experiences with pro-urokinase and potentiation of its fibrinolytic effect by urokinase and by tissue plasminogen activator
V Gurewich |
Journal of the American College of Cardiology | 1987 |
Differential reactivity of Glu-Gly-Arg-CH2Cl, a synthetic urokinase inhibitor, with single-chain and two-chain forms of urokinase-type plasminogen activator
HR LIJNEN, B HOEF, D COLLEN |
European Journal of Biochemistry | 1987 |
Activation with plasmin of two-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin
HR LIJNEN, B HOEF, D COLLEN |
European Journal of Biochemistry | 1987 |
Physiologic regulation and pathologic disorders of fibrinolysis
CW Francis, VJ Marder |
Human Pathology | 1987 |
Stimulation of the plasma fibrinolytic activity in rats by the prostacyclin analogue CG 4203
J Schneider |
Thrombosis Research | 1987 |
Historical overview of antithrombotic and thrombolytic therapy
GV Sharma |
The American Journal of Medicine | 1987 |
Thrombolytic effect of pro-urokinase in vitro
H Bando, K Okada, O Matsuo |
Fibrinolysis | 1987 |
The Pulmonary Circulation in Health and Disease
J Hughes |
The Pulmonary Circulation in Health and Disease | 1987 |
Review: Thrombolytic Therapy for Patients with Acute Myocardial Infarction
JT Willerson, M Winniforo, LM Buja |
The American Journal of the Medical Sciences | 1987 |
The Fibrinolytic System and Its Pharmacologic Activation for Thrombolysis
S Sherry |
Cardiology Clinics | 1987 |
Activation of the Fibrinolytic System
AK Robison, D Collen |
Cardiology Clinics | 1987 |
Coronary Thrombolysis with TissueType Plasminogen Activator
SR Bergmann, PA Ludbrook, BE Sobel |
Cardiology Clinics | 1987 |
Characterization of recombinant human single chain urokinase-type plasminogen activator mutants produced by site-specific mutagenesis of lysine 158
L Nelles, HR Lijnen, D Collen, WE Holmes |
The Journal of biological chemistry | 1987 |
Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study
V Ellis, MF Scully, VV Kakkar |
The Journal of biological chemistry | 1987 |
Preclinical Pharmacological Evaluation of Anisoylated Plasminogen Streptokinase Activator Complex:
H Ferres |
Drugs | 1987 |
Analysis of Coagulation and Fibrinolysis after Intravenous Anisoylated Plasminogen Streptokinase Activator Complex or Heparin in Patients with Acute Myocardial Infarction: A Belgian Multicentre Study
J Renkin, CC Beys, E Lavenne-Pardonge, H Pintens, J. |
Drugs | 1987 |
Fibrinogen and fibrin: Biochemistry and pathophysiology
AZ Budzynski, JR Shainoff |
Critical Reviews in Oncology/Hematology | 1986 |
Pharmacology of thrombolytic drugs
M Verstraete, D Collen |
Journal of the American College of Cardiology | 1986 |
Human neutrophil plasminogen activator is localized in specific granules and is translocated to the cell surface by exocytosis
JM Heiple, L Ossowski |
Journal of Experimental Medicine | 1986 |
Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: Effect on regional blood flow, infarct size and hemostasis
W Flameng, J Vanhaecke, DC Stump, FV de Werf, W Holmes, WA Guenzler, L Flohe, D Collen |
Journal of the American College of Cardiology | 1986 |
Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activator
HR Lijnen, BV Hoef, D Collen |
Biochimica et Biophysica Acta (BBA) - General Subjects | 1986 |
THROMBOLYSIS: AN EFFECTIVE THERAPY IN ACUTE CORONARY THROMBOSIS
HD White, RM Norris |
Australian and New Zealand Journal of Medicine | 1986 |
Release of both urokinase and tissue plasminogen activator from veins
A Kjaeldgaard, B Larsson, B Astedt |
Thrombosis Research | 1986 |
Specific fibrinolytic properties of different molecular forms of pro-urokinase from a monkey kidney cell culture
DC Rijken, DJ Binnema, P Los |
Thrombosis Research | 1986 |
Analytic Review: Thrombolytic Therapy in Acute Myocardial Infarction
PL Zwerner, JM Gore |
Journal of Intensive Care Medicine | 1986 |
Purification and characterization of recombinant single-chain urokinase produced in Escherichia coli
ME Winkler, M Blaber |
Biochemistry | 1986 |
Thrombolytic effect of single-chain pro-urokinase in a rabbit jugular vein thrombosis model
O Matsuo, H Bando, K Okada, K Tanaka, M Tsukada, Y Iga, H Arimura |
Thrombosis Research | 1986 |
Synergism of thrombolytic agents in vivo
D Collen, JM Stassen, DC Stump, M Verstraete |
Circulation | 1986 |
Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarction
FV de Werf, J Vanhaecke, H de Geest, M Verstraete, D Collen |
Circulation | 1986 |
Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex
S Ikram, S Lewis, C Bucknall, I Sram, N Thomas, R Vincent, D Chamberlain |
BMJ : British Medical Journal | 1986 |
Facts and Hopes in Thrombolysis in Acute Myocardial Infarction
S Effert, R von Essen, PG Hugenholtz, R Uebis, M Verstraete |
1986 | |
8 Advances in Clinical Fibrinolysis
LW Hessel, C Kluft |
Clinics in Haematology | 1986 |
Activation of plasminogen by pro-urokinase. I. Mechanism
HR Lijnen, C Zamarron, M Blaber, ME Winkler, D Collen |
The Journal of biological chemistry | 1986 |
Activation of plasminogen by pro-urokinase. II. Kinetics
D Collen, C Zamarron, HR Lijnen, M Hoylaerts |
The Journal of biological chemistry | 1986 |
Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures
DC Stump, HR Lijnen, D Collen |
The Journal of biological chemistry | 1986 |
Urokinase-related proteins in human urine. Isolation and characterization of single-chain urokinase (pro-urokinase) and urokinase-inhibitor complex
DC Stump, M Thienpont, D Collen |
The Journal of biological chemistry | 1986 |
Current Issues in Thrombosis Prevention with Antiplatelet Drugs:
G de Gaetano, C Cerletti, E Dejana, J Vermylen |
Drugs | 1986 |
Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins
N Toki, H Sumi, K Sasaki, I Boreisha, KC Robbins |
Journal of Clinical Investigation | 1985 |
Die Bedeutung des Endothels der Gefäßwand für die Aufrechterhaltung der Hämostase
U Delvos, G Müller-Berghaus |
Klinische Wochenschrift | 1985 |
Characterization of the high-affinity interaction between human plasminogen and pro-urokinase
HR LIJNEN, C ZAMARRON, D COLLEN |
European Journal of Biochemistry | 1985 |
Cloning and Expression of the Gene for Pro-urokinase in Escherichia coli
WE Holmes, D Pennica, M Blaber, MW Rey, WA Guenzler, GJ Steffens, HL Heyneker |
Bio/Technology | 1985 |
Fibrinogenolysis and fibrinolysis in normal volunteers and patients with thrombosis after infusion of urokinase
T Urano, T Kamiya, S Sakaguchi, Y Takada, A Takada |
Thrombosis Research | 1985 |
Antithrombotic therapy in coronary artery disease
V Bertelé, EW Salzman |
Arteriosclerosis (Dallas, Tex.) | 1985 |
Coronary thrombolysis in dogs with intravenously administered human pro-urokinase
D Collen, D Stump, F van de Werf, IK Jang, M Nobuhara, HR Lijnen |
Circulation | 1985 |
Relationship of the lytic state to successful reperfusion with standard- and low-dose intracoronary streptokinase
RL Rothbard, PG Fitzpatrick, CW Francis, DM Caton, WB Hood, VJ Marder |
Circulation | 1985 |
Acute Coronary Care 1986
RM Califf, GS Wagner |
1985 | |
Improvement of Myocardial Perfusion
J Meyer, R Erbel, HJ Rupprecht |
1985 | |
The Fibrinolytic System of the Vascular Wall
LA Erickson, RR Schleef, T Ny, DJ Loskutoff |
Clinics in Haematology | 1985 |
The fibrinolytic system in man
AP Reiner, WR Bell |
Critical Reviews in Oncology/Hematology | 1984 |
Kidney Plasminogen Activator: A Precursor Form of Human Urokinase With High Fibrin Affinity
T Kohno, P Hopper, JS Lillquist, RL Suddith, R Greenlee, DT Moir |
Bio/Technology | 1984 |
New approaches to thrombolytic therapy
D Collen, HR Lijnen |
Arteriosclerosis (Dallas, Tex.) | 1984 |
New Comprehensive Biochemistry
S Yamamoto |
New Comprehensive Biochemistry | 1983 |
Protides of the Biological Fluids
PA Small, RH Waldman |
Protides of the Biological Fluids | 1969 |
Verhandlungen der Deutschen Gesellschaft für Innere Medizin
B Schlegel |
1962 | |
Clinical Chemistry
RM Archibald |
Analytical Chemistry | 1953 |